Altimmune (ALT) Other Working Capital Changes (2018 - 2020)
Altimmune's (ALT) quarterly Other Working Capital Changes came in at -$18885.0 in Q1 2020, down 209.95% year-on-year from $17176.0 in Q2 2019, and down 151.23% on a QoQ basis from $36865.0 in Q4 2019.
Altimmune (ALT) Other Working Capital Changes (2018 - 2020) Analysis & Trends
Altimmune (ALT) has 3 years of Other Working Capital Changes data on file, last reported at -$18885.0 in Q1 2020.
- On a quarterly basis, Other Working Capital Changes fell 209.95% year-over-year to -$18885.0 in Q1 2020; TTM through Mar 2020 was -$14029.0, a 38.11% increase from a year earlier, with the FY2019 full-year figure at $22032.0, up 211.39% from the prior year.
- Other Working Capital Changes for Q1 2020 stood at -$18885.0, down from $36865.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for ALT reached as high as $1.8 million in Q2 2023 and fell as low as -$4.0 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged -$437117.6 across 5 years, with a median of -$228000.0 in 2024.
- Across the five-year window, Other Working Capital Changes jumped 845.2% in 2019 and plunged 209.95% in 2020, its largest moves.
- Year by year, Other Working Capital Changes stood at -$4947.0 in 2018, then soared by 845.2% to $36865.0 in 2019, then plunged by 151.23% to -$18885.0 in 2020.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$18885.0 in Q1 2020, $36865.0 in Q4 2019, and -$17635.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -18,885.00 |
| Mar 31, 2020 | -18,885.00 |
| Mar 31, 2020 | -18,885.00 |
| Dec 31, 2019 | 36,865.00 |
| Dec 31, 2019 | 36,865.00 |
| Dec 31, 2019 | 36,865.00 |
| Sep 30, 2019 | -17,635.00 |
| Sep 30, 2019 | -17,635.00 |
| Sep 30, 2019 | -17,635.00 |
| Jun 30, 2019 | -14,374.00 |
| Jun 30, 2019 | -14,374.00 |
| Jun 30, 2019 | -14,374.00 |
| Mar 31, 2019 | 17,176.00 |
| Mar 31, 2019 | 17,176.00 |
| Mar 31, 2019 | 17,176.00 |
| Dec 31, 2018 | -4,947.00 |
| Dec 31, 2018 | -4,947.00 |
| Dec 31, 2018 | -4,947.00 |
| Sep 30, 2018 | -17,447.00 |
| Sep 30, 2018 | -17,447.00 |